221 related articles for article (PubMed ID: 36743418)
1. Chikungunya virus entry and infectivity is primarily facilitated through cell line dependent attachment factors in mammalian and mosquito cells.
Reyes Ballista JM; Miazgowicz KL; Acciani MD; Jimenez AR; Belloli RS; Havranek KE; Brindley MA
Front Cell Dev Biol; 2023; 11():1085913. PubMed ID: 36743418
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya Virus Strains from Each Genetic Clade Bind Sulfated Glycosaminoglycans as Attachment Factors.
McAllister N; Liu Y; Silva LM; Lentscher AJ; Chai W; Wu N; Griswold KA; Raghunathan K; Vang L; Alexander J; Warfield KL; Diamond MS; Feizi T; Silva LA; Dermody TS
J Virol; 2020 Nov; 94(24):. PubMed ID: 32999033
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection.
Tanaka A; Tumkosit U; Nakamura S; Motooka D; Kishishita N; Priengprom T; Sa-Ngasang A; Kinoshita T; Takeda N; Maeda Y
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404855
[TBL] [Abstract][Full Text] [Related]
4. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
5. The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry.
Kirui J; Abidine Y; Lenman A; Islam K; Gwon YD; Lasswitz L; Evander M; Bally M; Gerold G
Cells; 2021 Jul; 10(7):. PubMed ID: 34359995
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.
Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of Chikungunya Virus with Its Receptor MXRA8 during Cell Attachment, Internalization, and Membrane Fusion.
Feng F; Bouma EM; Hu G; Zhu Y; Yu Y; Smit JM; Diamond MS; Zhang R
J Virol; 2023 May; 97(5):e0155722. PubMed ID: 37133449
[TBL] [Abstract][Full Text] [Related]
8. Loss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus Infectivity.
Acharya D; Paul AM; Anderson JF; Huang F; Bai F
PLoS Negl Trop Dis; 2015; 9(10):e0004139. PubMed ID: 26484530
[TBL] [Abstract][Full Text] [Related]
9. Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice.
Ashbrook AW; Burrack KS; Silva LA; Montgomery SA; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Nov; 88(21):12180-92. PubMed ID: 25142598
[TBL] [Abstract][Full Text] [Related]
10. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions.
Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA
J Virol; 2024 Jun; ():e0067924. PubMed ID: 38842335
[TBL] [Abstract][Full Text] [Related]
11. Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
Ashbrook AW; Lentscher AJ; Zamora PF; Silva LA; May NA; Bauer JA; Morrison TE; Dermody TS
mBio; 2016 May; 7(3):. PubMed ID: 27222471
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of Chikungunya Virus Cell Entry Unraveled by Single-Virus Tracking in Living Cells.
Hoornweg TE; van Duijl-Richter MKS; Ayala Nuñez NV; Albulescu IC; van Hemert MJ; Smit JM
J Virol; 2016 May; 90(9):4745-4756. PubMed ID: 26912616
[TBL] [Abstract][Full Text] [Related]
13. Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design.
Gardner CL; Hritz J; Sun C; Vanlandingham DL; Song TY; Ghedin E; Higgs S; Klimstra WB; Ryman KD
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2719. PubMed ID: 24587470
[TBL] [Abstract][Full Text] [Related]
14. G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
Wang S; Merits A
J Virol; 2022 Nov; 96(21):e0127822. PubMed ID: 36226983
[TBL] [Abstract][Full Text] [Related]
15. BHK-21 Cell Clones Differ in Chikungunya Virus Infection and MXRA8 Receptor Expression.
Yin P; Kielian M
Viruses; 2021 May; 13(6):. PubMed ID: 34063936
[TBL] [Abstract][Full Text] [Related]
16. Macropinocytosis dependent entry of Chikungunya virus into human muscle cells.
Lee CHR; Mohamed Hussain K; Chu JJH
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007610. PubMed ID: 31449523
[TBL] [Abstract][Full Text] [Related]
17. Chikungunya Virus Release is Reduced by TIM-1 Receptors Through Binding of Envelope Phosphatidylserine.
Ballista JMR; Hoover AJ; Noble JT; Acciani MD; Miazgowicz KL; Harrison SA; Tabscott GAL; Duncan A; Barnes DN; Jimenez AR; Brindley MA
bioRxiv; 2024 Jan; ():. PubMed ID: 38328121
[TBL] [Abstract][Full Text] [Related]
18. Early Events in Chikungunya Virus Infection-From Virus Cell Binding to Membrane Fusion.
van Duijl-Richter MK; Hoornweg TE; Rodenhuis-Zybert IA; Smit JM
Viruses; 2015 Jul; 7(7):3647-74. PubMed ID: 26198242
[TBL] [Abstract][Full Text] [Related]
19. Identification of Functional Determinants in the Chikungunya Virus E2 Protein.
Weber C; Berberich E; von Rhein C; Henß L; Hildt E; Schnierle BS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005318. PubMed ID: 28114368
[TBL] [Abstract][Full Text] [Related]
20. In silico identification of small molecule protein-protein interaction inhibitors: targeting hotspot regions at the interface of MXRA8 and CHIKV envelope protein.
Verma J; Subbarao N
J Biomol Struct Dyn; 2023 May; 41(8):3349-3367. PubMed ID: 35272566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
